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Abstract: Numerous studies have focused on the mechanism of aflatoxin B1 (AFB1) metabolism and its carcinogenic mechanism, but
how AFB1 is transported into hepatocytes and how it is transferred inside hepatocytes remains unknown. In this study, the AFB1interacting protein, estradiol 17 beta-dehydrogenase 5 (Akr1c6), was identified with an immobilized affinity chromatography technique
and LC-MS/MS. The interaction between Akr1c6 and AFB1 was confirmed with ELISA, and the results showed that Akr1c6 could
efficiently bind AFB1. Anti-Akr1c6 polyclonal antibody from rabbit was prepared, and the IC50 values of AFB1 to BRL (normal big
rat liver cells) and NRK (normal rat kidney cells) were detected using the MTT assay. It was found that the Akr1c6 expression level in
BRL was significantly affected under the IC50 value of AFB1 (P < 0.05), but no obvious expression difference of Akr1c6 was observed in
NRK. This suggested that Akr1c6 in liver cells participates in the transportation and/or metabolism of AFB1, and though Akr1c6 was
expressed in the kidneys, it did not play a role in AFB1 transportation or metabolism. The conclusions of this study lay a foundation
for further exploring the role of AFB1 binding proteins in the toxicology of AFB1 to hepatocytes and the pathway through which AFB1
enters hepatocytes and their nuclei.
Key words: Aflatoxin B1-binding protein, estradiol 17 beta-dehydrogenase 5, toxicology of AFB1, hepatocytes

1. Introduction
The discovery of aflatoxins (AFs) was a result of the
outbreak of turkey X disease in 1960 (1). AFs are
metabolites produced by various Aspergillus spp.
(including Aspergillus flavus). These are difuranocoumarin
compounds, including B1, B2, G1, G2, M1, and M2 (2–5).
The mycotoxins are known to have strong hepatotoxic and
carcinogenic effects and are regulated by feed/food law in at
least 100 countries (4). Among AFs, aflatoxin B1 (AFB1),
the most common one with higher toxicity than any other
aflatoxins, has been classified as a most important known
carcinogenic compound (Group 1) by the International
Agency for Research on Cancer (6). AFB1 toxicity is
activated by biotransformation into the exo-AFB1-8,9epoxide, which is mediated by cytochrome P450 located
predominantly in hepatocytes, making the liver the
primary target for AFB1 toxicity (7,8). Epidemiological
studies have demonstrated that direct chronic exposure
to AFB1 through diet was shown to cause liver cirrhosis,
which led to a high rate of hepatocellular carcinoma
(HCC) development, and AFB1 interacts synergistically
* These authors contributed equally to this work.
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with hepatitis B virus (HBV) and hepatitis C virus (HCV)
infection, which increases the risk of HCC (9,10).
For a long time, numerous studies have focused on
the mechanism of AFB1 metabolism and the carcinogenic
mechanism of AFB1. The DNA mutation mechanism
induced by AFB1 and its interaction with HBV has
been deeply explored (11–16). The knowledge on how
AFB1 enters hepatocytes and whether there is a need
for a protein vehicle to transport AFB1 into cells is still
very limited (17,18). Iwaki et al. (19) found a cytosolic
25-kDa AFB1-binding protein and speculated that the
25-kDa protein is involved in the intracellular process of
AFB1-mediated toxicity in 1983, and a 45-kDa protein
was estimated by Dirr and Schabort (20) to be the major
AFB1-binding component in 1987. Taggart et al. found
that multiple proteins are capable of binding to AFB1
(21). In this study, AFB1-binding proteins were screened
with the method of immobilized affinity chromatography
technology (IAC) developed by Zhuang et al. in 2016 and
identified by LC-MS/MS (22). The biofunctions of the
AFB1-binding proteins were further explored in vitro
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(with ELISA) and in vivo (with liver and kidney cell
lines). The findings in this research might pave the way for
clarifying the biofunction of the AFB1-binding protein in
the toxicity mechanism of AFB1 and reveal the pathway
by which AFB1 enters into and is transported within
hepatocytes.
2. Materials and methods
2.1. Detection and identification of the AFB1-binding
protein
The AFB1-binding protein was pulled down by the
method of IAC (22). The AFB1-binding proteins on BSAAFB1-covered PVDF transfer membrane were eluted
by precooling 2 M NaCl in phosphate-buffered saline
(PBS) buffer. After dialysis in PBS at 4 °C for 2 days and
condensation with PEG 20000, the elution solution was
further analyzed by LC-MS/MS. Finally, the data were
analyzed with UNIPRO (22).
2.2. Bioinformatics analysis
The Akr1c6 protein sequence from 8 species, Mus
musculus (XP_006516573.1), Peromyscus maniculatus
(XP_006987897.1), Meriones unguiculatus (BAF34659.1),
Colobus angolensis (XP_011811374.1), Homo sapiens
(XP_016871280.1), Pongo abelii (NP_001124803.1),
Macaca fascicularis (NP_001270525.1), and Microcebus
murinus (XP012596672.1), were downloaded from NCBI.
A phylogenetic tree was constructed with MEGA 5.1. The
protein domain was analyzed and constructed with IBS 1.0.
The Akr1c6 proteins were further aligned with Clustal X.
2.3. Cloning, sequencing, and expression of Akr1c6
Polyadenylated (poly(A)) RNA was isolated from livers of
Kunming mice using the TRIzol RNA extraction kit (23).
First-strand cDNA synthesis was performed using an AMV
First Strand cDNA Synthesis Kit (Promega, Beijing, China).
The cDNA of Akr1c6 was amplified using the forward primer
5′-TACGAATTCATGGATTCTAAGCAGCAGAC-3′
(EcoRI) and reverse primer 5′-GCCAAGCTTCCG
TTAGTATTCATCCC-3′ (HindIII) according to the
sequence from NCBI GenBank (NM_030611). Both the
amplified Akr1c6 sequence and expression vector pET28a(+) were double-digested with EcoRI and HindIII and
then ligated together. The recombinant plasmids were
transformed into E. coli DH5a cells. After checking by PCR
with the primers provided above, four randomly selected
clones were sequenced and aligned against the published
sequence (NM_030611). The positive recombinant
plasmid (pET-28a(+)-akr1c6) was transformed into E.
coli BL21 cells for expression with 0.2 mM isopropyl-β-Dthiogalactopyranoside.
2.4. Protein purification
Pellets of the induced BL21 with pET-28a(+)-akr1c6
were suspended in buffer D (20 mM Tris (pH 7.9), 5 mM

imidazole, and 0.5 M NaCl). After ultrasonic treatment,
the mixtures were centrifuged at 15,000 × g for 20 min, and
the suspension was incubated in a 1-mL Ni-NTA column
for 1 h at RT. The Ni-NTA columns were washed with 50
mL of buffer E (20 mM Tris (pH 7.9), 60 mM imidazole,
and 0.5 M NaCl) and then incubated with elution buffer
F (20 mM Tris (pH 7.9), 1 M imidazole, and 0.5 M NaCl)
five times. The collected eluates were dialyzed overnight in
PBS at 4 °C for 2 days and concentrated using PEG 8000
(24). Protein samples were confirmed by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).
2.5. Detection of Akr1c6–AFB1 interaction by ELISA
Wells 1 and 2 of the microplate were coated with bovine
serum albumin (BSA) and AFB1, wells 3 and 4 were
coated with BSA, wells 5 and 6 were the negative controls
(coated with BSA, with no first antibody applied), and
wells 7 and 8 were the positive controls (coated with
corresponding recombinant protein with His tag: Akr1c6,
thioredoxin (TRX), and green fluorescent protein (GFP)
protein). Recombinant Akr1c6 was then added to all
wells and anti-His antibody was added, except for wells
5 and 6, followed by the addition of 1/8000 diluted goat
antimouse IgG horseradish peroxidase antibody into all
wells, and wells were held at 37 °C for 60 min. Next, 100
µL of 3,3′,5,5′-tetramethylbenzidine substrate solution was
added. The reaction was terminated after 15 min by adding
50 µL of stopping solution (2 M H2SO4). Finally, the OD450
values of the wells were read with a microplate reader (25).
2.6. Immunization and titer detection of antiserum
Rabbits were immunized with purified Akr1c6 through
dorsal subcutaneous injection. The mixture of Akr1c6 and
complete Freund’s adjuvant was used for the first injection.
The later injections were administered with a mixture of
Akr1c6 and incomplete Freund’s adjuvant 3 times with
an interval of 1 week between each injection. Serum titer
was detected by enzyme-linked immune sorbent assay
(ELISA) (24).
2.7. The expression level of Akr1c6 under the IC50 value
of AFB1
MTT analysis was employed to detect the IC50
(half inhibitory concentration) of AFB1 to BRL (normal big
rat liver) and NRK (normal rat kidney) cells. Both cell lines
(at a concentration of 106/mL) were plated into 96-wells
plates (100 µL/well) and exposed to AFB1 in DMSO at
different concentrations (10, 20, 30, 40, 50, 60, 70, 80, and
90 µg/mL). Cell viabilities were determined at 490 nm
with an MTT cell proliferation and cytotoxicity detection
kit (KeyGEN Biotech, Nanjing, China). The IC50 values
of AFB1 were extrapolated from relative cell viability vs.
log [AFB1 concentration] curves (22). The BRL and NRK
cell strains were incubated under the IC50 value of AFB1
for 24 h. In the control group, cells were inoculated with
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DMSO (BRL: 0.61%; NRK: 0.67%). Cells were collected
and centrifuged at 1000 × g for 5 min. Protein samples
were prepared by adding 100 µL of RIPA lysis buffer/well
(Beyotime, Haimen, China) into the cell pellet. Western
blotting analysis was performed according to the protocol
used by Zhuang et al. with minor adjustment, and β-actin
was used as inner reference (24).
2.8. Statistical analysis
Data were presented as mean ± standard deviation (SD).
The presence of statistical differences was determined
by one-way ANOVA, and statistical significance was
recognized at P < 0.05.
3. Results
3.1. Identification of AFB1-binding protein with LC-MS/
MS
AFB1-binding proteins were pulled down by the method
of IAC from the total liver proteins. Two different
expression protein bands (data not shown) were collected
and identified with LC-MS/MS. Estradiol 17 betadehydrogenase 5 (Akr1c6) was identified from band A
(shown in the Table) and subjected to further analysis.
3.2. Bioinformatics analysis of Akr1c6
The results showed that Akr1c6 from Peromyscus
maniculatus and Meriones unguiculatus had higher
similarity with that from M. musculus (they are rodents),
and the highest similarity was found between M. musculus
and M. unguiculatus (80.8%) as shown in Figure 1a. Lower
homology was found between M. musculus and the other
five nonrodent species, and the lowest similarity was 60.1%
between M. musculus and Pongo abelii. A phylogenetic
tree of these species was constructed, in which three
rodent species were classified into a cluster, and the other 5
primate species were grouped into another cluster (Figure
1b). The protein domain in Akr1c6 was analyzed with IBS
1.0 and an NADP-dependent oxidoreductase domain was
found in all 8 species (Figure 1c).
3.3. Cloning, sequencing, and expression of Akr1c6
Poly(A) RNA was isolated, and cDNA was synthesized by
reverse transcription. The target gene akr1c6 was amplified
with the primers shown in Section 2. The PCR product
was analyzed by agarose gel electrophoresis and the results

showed a 972-bp band (Figure 2a), which indicated that
the gene had been amplified. The recombinant plasmid
was transformed into competent E. coli DH5a cells.
After confirmation by PCR analysis, five transcripts
were sequenced by Sangon Biotech (Shanghai, China).
Three verified pET-28a-akr1c6 recombined vectors were
transferred into E. coli BL21 for protein expression.
Analysis of the induced E. coli BL21 cell pellet by SDSPAGE electrophoresis indicated a band of ~37 kDa (Figure
2b, lane 3). No corresponding band was found in the
control strain (Figure 2b, lane 2). The expression product
was purified by Ni2+-NTA, and the buffer E eluent was
collected and analyzed by SDS-PAGE. It showed Akr1c6
(~37 kDa) had been purified (Figure 2b, lane 4).
3.4. Interactions between Akr1c6 protein and AFB1 in
vitro
The results showed that Akr1c6 specifically bound to AFB1
in vitro (Figure 3a, Akr1c6, wells 1 and 2). The antibodies
bound to the His tag on the recombinant Akr1c6 protein
but did not bind to BSA (Figure 3a, Akr1c6, wells 3–6).
Wells 7 and 8 showed that anti-His antibody efficiently
bound to the His tag. The histogram from the ELISA
results showed that protein Akr1c6 effectively bound to
AFB1 compared to TRX and GFP (P < 0.05, Figure 3b).
3.5. Anti-Akr1c6 antiserum preparation
Several microliters of antiserum were collected from
the ear vein of rabbits. The results from the ELISA assay
showed that the titer of rabbit-1 was about 1/64,000 and
that of rabbit-2 was about 1/128,000 (Figure 4). Both fully
met the requirements for further Western blotting analysis.
3.6. The expression level of Akr1c6 under the IC50 value
of AFB1
The MTT assay was employed for the determination
of cell viability of rat liver cell line BRL and kidney cell
line NRK. IC50 values (BRL: 61.2 µg/mL; NRK: 67.1 µg/
mL) were calculated from the exponential equations
shown in Figures 5a and b. According to the results of
Western blotting (Figure 6a), the Akr1c6 level in BRL
was significantly downregulated (Figure 6c BRL, P <
0.05) under the IC50 value of AFB1. For NRK, no obvious
difference was observed between the AFB1-treated group
and the control group (DMSO-treated).

Table. Identification of AFB1-binding protein.
No.

Accession number

Sequence
coverage

Peptide hits

Molecular
weight

pI

Score

Protein summary

1

IPI: IPI00111950.1

27.86

5

37.0

8.28

85.07

Estradiol 17 betadehydrogenase 5

2

IPI: IPI00474446.4

10.16

2

36.1

5.08

18.79

Eukaryotic translation
initiation factor 2 subunit 1
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Figure 1. Bioinformatics analysis of Akr1c6. a) Amino acid alignment of M. musculus Akr1c6 and
putative orthologs from P. maniculatus, M. unguiculatus, C. angolensis, H. sapiens, P. abelii, M. fascicularis,
and M. murinus. Clustal X was utilized in this analysis. b) Diagram showing the phylogenetic tree of the
8 species above. c) Diagram showing the domains of Akr1c6 in the 8 species above. interPro (http://www.
ebi.ac.uk/interpro/scan.html) and IBS 1.0 were used in the analysis.

4. Discussion
The method of IAC was adopted in this study to screen
AFB1-binding proteins from mice livers (22). Akr1c6, a
member of the aldo-keto reductase family, was identified
by LC-MS/MS analysis (Table). The akr1c6 gene was
coded with 1359-bp nucleotide residues, and it encodes
the Akr1c6 protein with 323 amino acid residues. Akr1c6
was reported to be mainly expressed in the liver (26).
In this study, Akr1c6 was also found in the kidney by
western blotting analysis. Bioinformatics analysis in this
study showed that the akr1c6 gene was commonly found
among rodent and primate species with high similarity

(at least 60.1%), suggesting that akr1c6 plays a similar
and important role in the biological activity of rodents
and primates. Enzymes in the aldo-keto reductase family
catalyze redox transformations involved in biosynthesis,
intermediary metabolism, and detoxification. Substrates of
these enzymes include glucose, steroids, glycosylation end
products, lipid peroxidation products, and environmental
pollutants. Enzymes in this family also play an important
role in the phase II detoxification of a large number of
pharmaceuticals, drugs, and xenobiotics (27). AKRs are
thought to be key AF-detoxifying enzymes; AKR-7A2
genes were found to be induced in HepG2 cells (28,29).
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Figure 2. Cloning, sequencing, and expression of Akr1c6. a) Amplification of the akr1c6 gene fragment from cDNA (1: DL2000 marker;
2 and 3: akr1c6 gene fragment). b) The SDS-PAGE analysis of Akr1c6 expression and purification (1: Mid-range Protein molecular
weight markers; 2: control (empty vector pET-28a); 3: SDS-PAGE of total proteins of recombinant plasmid (pET-28a-akr1c6); 4: purified
Akr1c6 protein by Ni2+-NTA).

Figure 3. Verification of the interaction between Akr1c6 protein and AFB1 in vitro. a) ELISA analysis of the interaction between AFB1
and Akr1c6. b) Relative levels of the binding interaction. Data are presented as mean ± SD (n = 3, P < 0.05).
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Figure 4. Titer of antiserum from rabbit-1 and rabbit-2. a) The ELISA results for serum from rabbit-1 and 2. b) The curve graph
according to the OD450 volume of each antiserum dilution (1/1000, 1/2000, 1/4000, 1/8000, 1/16,000, 1/32,000, 1/64,000, and 1/128,000).

Figure 5. The relative cell viability of cells treated with AFB1. a) The exponential equations according to the results from the MTT assay
for the BRL cell strain (4 repetitions). b) The exponential equations according to the results from the MTT assay for the NRK cell strain
(4 repetitions).

AFB1 was reported as a hepatotoxic secondary metabolic
product (30), and the liver cell strain BRL was chosen in
this study to detect if Akr1c6 plays a role in the toxicology
of AFB1 to hepatocytes, while kidney cell line NRK was
set as a negative control. By preparation of the anti-Akr1c6
polyclonal antibody, the Akr1c6 expression level was found
significantly downregulated under the IC50 value of AFB1
in the liver cell strain (BRL), but no obvious expression
difference of Akr1c6 was found between control and
AFB1-treated kidney cells (NRK). The results suggested
that Akr1c6 directly participated in the transport and/or
metabolism of AFB1 in liver cells, but not in kidney cells
(even though some degree of expression was observed in
the kidneys). In view of the result from bioinformatics
that the human Akr1c6 protein sequence was not in the

same cluster of the protein sequence from rats (Figure 1b),
it would be worthwhile to repeat our work in human cell
lines to confirm the biofunction of the Akr1c6 protein
in the process of AFB1 transportation into or between
human cells. The results of this study laid a foundation for
further exploration of the role of AFB1-binding proteins
in the toxicology of AFB1 to hepatocytes and the pathway
through which AFB1 enters hepatocytes.
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Figure 6. The expression level of Akr1c6 under IC50 concentration of AFB1. a) Detection of Akr1c6 expression level in
BRL cell strain by western blotting analysis (3 repetitions). b) Akr1c6 expression level detection in NRK cell strain by
western blotting analysis (3 repetitions). c) The relative expression amount of Akr1c6 from BRL and NRK cell strains
(P < 0.05).
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